Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-13-003306)

Filing Details

Accession Number:: 0001213900-13-003306
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-26 16:18:17
Reporting Period:: 2013-06-25

Filing Date:: 2013-06-26
Accepted Time:: 2013-06-26 16:18:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
812796	Soligenix Inc.	SNGX	Pharmaceutical Preparations (2834)	411505029

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1068029	J Christopher Schaber	29 Emmons Drive, Suite C-10 Princeton NJ 08540	Chairman, Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-06-25	9,523	$1.05	59,681	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants	Acquisiton	2013-06-25	7,143	$0.00	7,143	$1.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,142	2013-06-25	2018-06-25	No	4	P	Direct